MECP2 and myelodysplastic syndrome: We qualitatively assessed the directionality of gene expression using two methods: 1) by using principal component analysis and 2) by ranking the relative expression in unaffected control cell lines, MECP2 ASO-treated unaffected control cell lines, MDS cell lines, and MECP2 ASO-treated MDS cell lines per gene.